DNA Sciences Partners With Bristol-Myers Squibb To Investigate Potential Disease Association Of Target Gene
10-Oct-2001
"Our effort with Bristol-Myers Squibb is a continuation of DNA Sciences' work to apply genetics to pharmaceutical discovery and development," said Steven B. Lehrer, president and chief operating officer at DNA Sciences. "DNA Sciences is working closely with Bristol-Myers Squibb to determine which genetic variations are associated with disease and potentially drug response."
Organizations
Bristol-Myers Squibb
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.